Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Complete replication of hepatitis C virus in cell culture.

Lindenbach BD, Evans MJ, Syder AJ, Wölk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM.

Science. 2005 Jul 22;309(5734):623-6. Epub 2005 Jun 9.

2.

Construction of the Vero cell culture system that can produce infectious HCV particles.

Guo J, Yan R, Xu G, Li W, Zheng C.

Mol Biol Rep. 2009 Jan;36(1):111-20. Epub 2007 Oct 25.

PMID:
17960493
3.

Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins.

Ishii K, Murakami K, Hmwe SS, Zhang B, Li J, Shirakura M, Morikawa K, Suzuki R, Miyamura T, Wakita T, Suzuki T.

Biochem Biophys Res Commun. 2008 Jul 4;371(3):446-50. doi: 10.1016/j.bbrc.2008.04.110. Epub 2008 Apr 28.

PMID:
18445476
4.

Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles.

Doerrbecker J, Friesland M, Riebesehl N, Ginkel C, Behrendt P, Brown RJ, Ciesek S, Wedemeyer H, Sarrazin C, Kaderali L, Pietschmann T, Steinmann E.

Hepatology. 2014 Aug;60(2):508-20. doi: 10.1002/hep.27190. Epub 2014 Jun 24.

PMID:
24771613
5.

Development of mouse hepatocyte lines permissive for hepatitis C virus (HCV).

Aly HH, Oshiumi H, Shime H, Matsumoto M, Wakita T, Shimotohno K, Seya T.

PLoS One. 2011;6(6):e21284. doi: 10.1371/journal.pone.0021284. Epub 2011 Jun 22.

6.

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.

Lohmann V, Körner F, Koch J, Herian U, Theilmann L, Bartenschlager R.

Science. 1999 Jul 2;285(5424):110-3.

7.

Immunogenic and functional organization of hepatitis C virus (HCV) glycoprotein E2 on infectious HCV virions.

Keck ZY, Xia J, Cai Z, Li TK, Owsianka AM, Patel AH, Luo G, Foung SK.

J Virol. 2007 Jan;81(2):1043-7. Epub 2006 Nov 1.

8.

Inducible system in human hepatoma cell lines for hepatitis C virus production.

Lim SP, Soo HM, Tan YH, Brenner S, Horstmann H, MacKenzie JM, Ng ML, Lim SG, Hong Wj.

Virology. 2002 Nov 10;303(1):79-99.

9.

Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.

Gottwein JM, Bukh J.

Adv Virus Res. 2008;71:51-133. doi: 10.1016/S0065-3527(08)00002-X. Review.

PMID:
18585527
10.

Novel function of CD81 in controlling hepatitis C virus replication.

Zhang YY, Zhang BH, Ishii K, Liang TJ.

J Virol. 2010 Apr;84(7):3396-407. doi: 10.1128/JVI.02391-09. Epub 2010 Jan 20.

11.

Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.

Horscroft N, Bellows D, Ansari I, Lai VC, Dempsey S, Liang D, Donis R, Zhong W, Hong Z.

J Virol. 2005 Mar;79(5):2788-96.

12.

Replication of the hepatitis C virus in cell culture.

Bartenschlager R, Kaul A, Sparacio S.

Antiviral Res. 2003 Oct;60(2):91-102. Review.

PMID:
14638404
13.

Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding.

Triyatni M, Vergalla J, Davis AR, Hadlock KG, Foung SK, Liang TJ.

Virology. 2002 Jun 20;298(1):124-32.

14.

Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection.

Crotta S, Brazzoli M, Piccioli D, Valiante NM, Wack A.

J Hepatol. 2010 Feb;52(2):183-90. doi: 10.1016/j.jhep.2009.11.003. Epub 2009 Dec 16.

PMID:
20015567
15.

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells.

Witteveldt J, Evans MJ, Bitzegeio J, Koutsoudakis G, Owsianka AM, Angus AG, Keck ZY, Foung SK, Pietschmann T, Rice CM, Patel AH.

J Gen Virol. 2009 Jan;90(Pt 1):48-58. doi: 10.1099/vir.0.006700-0.

16.
17.

Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement.

Chen Z, Zhu Y, Ren Y, Tong Y, Hua X, Zhu F, Huang L, Liu Y, Luo Y, Lu W, Zhao P, Qi Z.

PLoS One. 2011 Apr 19;6(4):e18933. doi: 10.1371/journal.pone.0018933.

18.

Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein.

Owsianka AM, Tarr AW, Keck ZY, Li TK, Witteveldt J, Adair R, Foung SK, Ball JK, Patel AH.

J Gen Virol. 2008 Mar;89(Pt 3):653-9. doi: 10.1099/vir.0.83386-0.

19.

Hepatitis C virus: virology and life cycle.

Kim CW, Chang KM.

Clin Mol Hepatol. 2013 Mar;19(1):17-25. doi: 10.3350/cmh.2013.19.1.17. Epub 2013 Mar 25. Review.

20.

Novel chimeric genotype 1b/2a hepatitis C virus suitable for high-throughput screening.

Zhang Y, Weady P, Duggal R, Hao W.

Antimicrob Agents Chemother. 2008 Feb;52(2):666-74. Epub 2007 Nov 26.

Items per page

Supplemental Content

Write to the Help Desk